KMTS
What one share of Kestra Medical Technologies holds
Surgical and Medical Instruments and Apparatus
We are a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease through connected monitoring, therapeutic intervention, and data-driven clinical insights.
Kestra Medical Technologies’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-07-31; the balance sheet is as of 2026-07-31.
| Sales | $1.91 |
|---|---|
| Profit | −$2.68 |
| Capex (buildings and equipment) | $0.63 |
| Free cash flow | −$2.19 |
| Cash and investments | $1.16 |
| Debt | $1.22 |
| Book value | $3.75 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2024 | $1.40 | −$5.07 | $0.61 | −$4.25 | — | — |
| 2025 | $2.43 | −$5.13 | $0.93 | −$4.09 | — | — |
| 2026 | $1.76 | −$2.43 | $0.64 | −$2.15 | — | $4.45 |